−0.6NOK
−10.65 MNOK
135.15 MNOK
9.33 M
About GENTIAN DIAGNOSTICS ASA
Sector
Industry
CEO
Hilja Ibert
Website
Headquarters
Moss
Employees (FY)
58
Founded
2001
ISIN
NO0010748866
FIGI
BBG00FJC6841
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. Its products include GCAL Calprotrectin, Crystatin C, Retinol-Binding Protein, Canine CRP, SARS-CoV-2 Total Ab, NT-proBNP Pre-Launch, BÜHLMANN products, IFU documents, and safety data sheets. The company was founded by Erling M. H. Sundrehagen and Bård Sundrehagen in 2001 and is headquartered in Moss, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GENT is 36.00 NOK — it has increased by 0.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange GENTIAN DIAGNOSTICS ASA stocks are traded under the ticker GENT.
GENTIAN DIAGNOSTICS ASA is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for GENTIAN DIAGNOSTICS ASA has a max estimate of 54.00 NOK and a min estimate of 54.00 NOK.
GENT earnings for the last quarter are −0.37 NOK whereas the estimation was −0.37 NOK which accounts for −1.78% surprise. Estimated earnings for the next quarter are −0.13 NOK. See more details about GENTIAN DIAGNOSTICS ASA earnings.
GENTIAN DIAGNOSTICS ASA revenue for the last quarter amounts to 25.12 M NOK despite the estimated figure of 24.42 M NOK. In the next quarter revenue is expected to reach 30.51 M NOK.
Yes, you can track GENTIAN DIAGNOSTICS ASA financials in yearly and quarterly reports right on TradingView.
Like other stocks, GENT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENTIAN DIAGNOSTICS ASA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 58.00 employees. See our rating of the largest employees — is GENTIAN DIAGNOSTICS ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENTIAN DIAGNOSTICS ASA EBITDA is −3.92 M NOK, and current EBITDA margin is −5.18%. See more stats in GENTIAN DIAGNOSTICS ASA financial statements.